Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

New Method Helps Link Genomic Variation to Protein Production

Published: Friday, November 09, 2012
Last Updated: Friday, November 09, 2012
Bookmark and Share
Research presented at American Society of Human Genetics 2012.

Scientists have adopted a novel laboratory approach for determining the effect of genetic variation on the efficiency of the biological process that translates a gene’s DNA sequence into a protein, such as hemoglobin, according to a presentation at the American Society of Human Genetics 2012 meeting in San Francisco.

In the 0.1% of the DNA that differs between any two individuals, scientists search for the biological mechanisms underlying human genetic differences, including disease susceptibility.

”How exactly these slight changes in the DNA affect the biology of the human body is not known in most cases,” said Constantin Polychronakos, M.D., professor of pediatrics, experimental medicine and human genetics at McGill University, Montreal, Canada.

“We decided to investigate the possibility that some of these changes may alter the translation of RNA into protein, a question that had not been systematically examined before,” he added.

Translation is the final stage of gene expression at which the gene’s DNA recipe for a protein can be modified, said McGill University scientist Quan Li, Ph.D., who presented the research.

In general, genomic studies have focused on finding links between diseases and variation in DNA. However, the new study takes a big step toward understanding how that variation affects the production of proteins, which are the molecules that most directly affect health and disease.

The study was designed to determine the effect of single-nucleotide polymorphisms (SNPs), which are variations in the DNA sequence, on the process of translation, Dr. Li said.

Translation begins when a gene’s DNA sequence is transcribed into the messenger RNA (mRNA) molecule that carries the transcript, or the blueprint for the protein encoded by the gene, to ribosomes, where proteins are manufactured in a cell.

Dr. Li and his colleagues developed a novel and scalable method that uses the binding of mRNAs to ribosomes as a proxy for translational efficiency of mRNAs that differ from one another because of SNPs.

“Because efficiently translated transcripts associate with multiple ribosomes while less active ones with fewer or no ribosomes, we hypothesized that functional transcripts would show a detectable shift in this distribution,” said Dr. Li.

Huiqi Qu, Ph.D., co-investigator of this study and assistant professor at the University of Texas School of Public Health, Brownsville, said, “The results of the proof-of-principle pilot study have clearly shown translational differences between mRNAs that differ only slightly from one another can be detected at a transcriptome-wide scale.” The transcriptome refers to the multiple types of RNAs that function in a cell.

“This study may represent the ‘tip of the iceberg,’ and its application to larger sample sizes will facilitate a shift toward functional genomics,” said Dr. Polychronakos. “Functional genomics tells us how genetic variation affects disease and points more directly toward possible therapies.”

“It will add an important tool in the evaluation of genetic loci associated with complex disorders,” Dr. Polychronakos added.

The researchers’ presentation is titled, “Translational cis-regulation of gene expression in the human genome: the effect of human single nucleotide polymorphisms.”


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

ASHG, The Jackson Laboratory Launch Educational Collaboration
New programs aim to integrate genetics and genomics into medicine.
Friday, June 13, 2014
DNA Variants Explain Over 10% of Inherited Genetic Risk for Heart Disease
About 10.6% of the inherited genetic risk for developing coronary artery disease (CAD) can be explained by specific DNA variations.
Monday, November 12, 2012
Scientific News
Long Telomeres Associated with Increased Lung Cancer Risk
Genetic predisposition for long telomeres predicts increased lung adenocarcinoma risk.
Expanding the Brain
A team of researchers has identified more than 40 new “imprinted” genes, in which either the maternal or paternal copy of a gene is expressed while the other is silenced.
Identifying a Key Growth Factor in Cell Proliferation
Researchers discover that aspartate is a limiter of cell proliferation.
Study Uncovers Target for Preventing Huntington’s Disease
Scientists from Cardiff University believe that a treatment to prevent or delay the symptoms of Huntington’s disease could now be much closer, following a major breakthrough.
The Genetic Roots of Adolescent Scoliosis
Scientists at the RIKEN Center for Integrative Medical Sciences in collaboration with Keio University in Japan have discovered a gene that is linked to susceptibility of Scoliosis.
A Gene-Sequence Swap Using CRISPR to Cure Haemophilia
For the first time chromosomal defects responsible for hemophilia have been corrected in patient-specific iPSCs using CRISPR-Cas9 nucleases
New Tool Uses 'Drug Spillover' to Match Cancer Patients with Treatments
Researchers have developed a new tool that improves the ability to match drugs to disease: the Kinase Addiction Ranker (KAR) predicts what genetics are truly driving the cancer in any population of cells and chooses the best "kinase inhibitor" to silence these dangerous genetic causes of disease.
Understanding the Molecular Origin of Epigenetic Markers
Researchers at IRB Barcelona discover the molecular mechanism that determines how epigenetic markers influence gene expression.
New Tech Enables Epigenomic Analysis with a Mere 100 Cells
A new technology that will dramatically enhance investigations of epigenomes, the machinery that turns on and off genes and a very prominent field of study in diseases such as stem cell differentiation, inflammation and cancer has been developed by researchers at Virginia Tech.
Access Denied: Leukemia Thwarted by Cutting Off Link to Environmental Support
A new study reveals a protein’s critical – and previously unknown -- role in the development and progression of acute myeloid leukemia (AML), a fast-growing and extremely difficult-to-treat blood cancer.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!